TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
CureVac ( (CVAC) ) just unveiled an announcement.
On November 25, 2025, CureVac N.V. announced the results of its Extraordinary General Meeting, where shareholders overwhelmingly approved BioNTech SE’s public exchange offer for all outstanding shares in CureVac, with over 99.16% of votes in favor. The approval includes a legal merger and the appointment of new directors, marking a significant step in CureVac’s strategic alignment with BioNTech, potentially impacting its market positioning and operational dynamics.
The most recent analyst rating on (CVAC) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on CureVac stock, see the CVAC Stock Forecast page.
Spark’s Take on CVAC Stock
According to Spark, TipRanks’ AI Analyst, CVAC is a Outperform.
CureVac’s strong financial performance and attractive valuation are the primary drivers of its overall score. The company’s robust profitability metrics and low leverage enhance its financial stability. However, technical analysis indicates some short-term bearish momentum, which slightly offsets the positive financial and valuation aspects.
To see Spark’s full report on CVAC stock, click here.
More about CureVac
CureVac N.V. is a pioneering multinational biotech company founded in 2000, focusing on the development of transformative medicines based on messenger RNA (mRNA) technology. The company has been instrumental in advancing mRNA technology for medical applications, including the production of mRNA vaccines against COVID-19. CureVac is currently expanding its mRNA applications into new therapeutic areas, including cancer immunotherapy and prophylactic vaccines, leveraging advanced omics and computational tools. Headquartered in Tübingen, Germany, CureVac operates in the Netherlands, Belgium, Switzerland, and the U.S.
Average Trading Volume: 560,408
Technical Sentiment Signal: Sell
Current Market Cap: $1.19B
Find detailed analytics on CVAC stock on TipRanks’ Stock Analysis page.